Experienced in Exercise-Induced Anaphylaxis (EIA)

Dr. Martha M. Tarpay

Allergy and Immunology
4200 W Memorial Rd, 
Okalhoma City, OK 
 (1395.0 mi)
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients
Offers Telehealth
Experienced in Exercise-Induced Anaphylaxis (EIA)
4200 W Memorial Rd, 
Okalhoma City, OK 
 (1395.0 mi)
OverviewInsuranceLocationsClinical Research

Overview

Martha Tarpay is an Allergy and Immunologist in Okalhoma City, Oklahoma. Dr. Tarpay and is rated as an Experienced provider by MediFind in the treatment of Exercise-Induced Anaphylaxis (EIA). Her top areas of expertise are Bloom Syndrome, Urticaria Pigmentosa, Primary Immunodeficiency (PID), and Hives. Dr. Tarpay is currently accepting new patients.

Her clinical research consists of co-authoring 2 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Allergy and Immunology
Licenses
Allergy & Immunology in OK
Hospital Affiliations
Mercy Hospital Oklahoma City, Inc
Languages Spoken
English
Hungarian
Gender
Female

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  UnitedHealthcare
  •  Humana

Locations

4200 W Memorial Rd, Okalhoma City, OK 73120

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions
A Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions
Enrollment Status: Recruiting
Publish Date: September 27, 2024
16-Week Randomized Double-Blind Placebo Controlled Parallel-Group Multicenter Study Evaluating the Efficacy and Safety of OPN-375 186 μg Twice a Day in Adolescents With Bilateral Nasal Polyps Followed With 12-Week Open-Label Treatment Phase
16-Week Randomized Double-Blind Placebo Controlled Parallel-Group Multicenter Study Evaluating the Efficacy and Safety of OPN-375 186 μg Twice a Day in Adolescents With Bilateral Nasal Polyps Followed With 12-Week Open-Label Treatment Phase
Enrollment Status: Recruiting
Publish Date: September 26, 2023
Intervention Type: Drug
Study Drug: OPN-375
Study Phase: Phase 3
A Randomised, Double-blind, Parallel Group Phase III Study to Assess the Efficacy and Safety of 100 mg SC Depemokimab in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) - ANCHOR-2 (depemokimAb iN CHrOnic Rhinosinusitis)
A Randomised, Double-blind, Parallel Group Phase III Study to Assess the Efficacy and Safety of 100 mg SC Depemokimab in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) - ANCHOR-2 (depemokimAb iN CHrOnic Rhinosinusitis)
Enrollment Status: Completed
Publish Date: January 16, 2025
Intervention Type: Drug, Biological
Study Phase: Phase 3
A Multi-center, Single-Sequence, Open-label Study to Evaluate IGSC 20% Biweekly Dosing in Treatment-Experienced Subjects and Loading/Maintenance Dosing in Treatment-Naïve Subjects With Primary Immunodeficiency
A Multi-center, Single-Sequence, Open-label Study to Evaluate IGSC 20% Biweekly Dosing in Treatment-Experienced Subjects and Loading/Maintenance Dosing in Treatment-Naïve Subjects With Primary Immunodeficiency
Enrollment Status: Completed
Publish Date: September 29, 2023
Intervention Type: Biological
Study Phase: Phase 4
A Randomised, Double-blind, Parallel Group, Multicentre, Stratified, Study Evaluating the Efficacy and Safety of Once Daily Fluticasone Furoate/Vilanterol Inhalation Powder Compared to Once Daily Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Participants Aged 5 to 17 Years Old (Inclusive) Currently Uncontrolled on Inhaled Corticosteroids
A Randomised, Double-blind, Parallel Group, Multicentre, Stratified, Study Evaluating the Efficacy and Safety of Once Daily Fluticasone Furoate/Vilanterol Inhalation Powder Compared to Once Daily Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Participants Aged 5 to 17 Years Old (Inclusive) Currently Uncontrolled on Inhaled Corticosteroids
Enrollment Status: Completed
Publish Date: May 09, 2023
Intervention Type: Drug
Study Drugs: Fluticasone Furoate, Vilanterol
Study Phase: Phase 3
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Enrollment Status: Completed
Publish Date: January 30, 2019
Intervention Type: Other
Study Phase: Not Applicable
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Enrollment Status: Completed
Publish Date: June 08, 2017
Intervention Type: Other
Study Phase: Not Applicable
View 5 Less Clinical Trials

2 Total Publications

The effect of GSK2190915, a 5-lipoxygenase-activating protein inhibitor, on exercise-induced bronchoconstriction.
The effect of GSK2190915, a 5-lipoxygenase-activating protein inhibitor, on exercise-induced bronchoconstriction.
Journal: Allergy and asthma proceedings
Published: April 11, 2014
Similar Doctors
Tim D. Trojan
Advanced in Exercise-Induced Anaphylaxis (EIA)
Dr. Tim D. Trojan
Allergy and Immunology
Advanced in Exercise-Induced Anaphylaxis (EIA)
Dr. Tim D. Trojan
Allergy and Immunology

Allergy Partners Of Oklahoma - Enid

3201 North Van Buren Street, 
Enid, OK 
 (59.1 mi)
580-366-0844
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Tim Trojan is an Allergy and Immunologist in Enid, Oklahoma. Dr. Trojan and is rated as an Advanced provider by MediFind in the treatment of Exercise-Induced Anaphylaxis (EIA). His top areas of expertise are Sinusitis, Grass Allergy, Allergic Rhinitis, and Hives.

Experienced in Exercise-Induced Anaphylaxis (EIA)
Dr. Richard T. Hatch
Allergy and Immunology | Pediatrics
Experienced in Exercise-Induced Anaphylaxis (EIA)
Dr. Richard T. Hatch
Allergy and Immunology | Pediatrics

Oklahoma Allergy And Asthma Clinic

3560 S. Boulevard St. Ste 150, 
Edmond, OK 
 (6.5 mi)
405-235-0040
Languages Spoken:
English, Spanish, Vietnamese
See accepted insurances
Accepting New Patients
Offers Telehealth

Richard Hatch is an Allergy and Immunologist and a Pediatrics provider in Edmond, Oklahoma. Dr. Hatch and is rated as an Advanced provider by MediFind in the treatment of Exercise-Induced Anaphylaxis (EIA). His top areas of expertise are Grass Allergy, Allergic Rhinitis, Sinusitis, and Exercise-Induced Anaphylaxis (EIA). Dr. Hatch is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile